Explore more publications!

Press Releases

WISHIN Partners with PointClickCare to Improve the Continuity of Care for Wisconsinites
New Clinical Data Demonstrate that VIVUS’ QSYMIA® in Combination with Digitally Enhanced Lifestyle Interventions (DELI) Leads to Significantly Greater Reductions in Weight and Cardiovascular Risk Compared with DELI Alone in Adults with Obesity
Navitas Organics Voluntarily Recalls Select Lots of 8oz Organic Chia Seeds Because of Possible Health Risk

Navitas Organics Voluntarily Recalls Select Lots of 8oz Organic Chia Seeds Because of Possible Health Risk

Da Vinci 5 Cleared for Cardiac Procedures
IKM Recalls Product Because of Possible Health Risk

IKM Recalls Product Because of Possible Health Risk

Education at ACHS Meets Growing Demand for Wellness Careers
Navitas Organics Voluntarily Recalls Select Lots of 8oz Organic Chia Seeds Because of Possible Health Risk

Navitas Organics Voluntarily Recalls Select Lots of 8oz Organic Chia Seeds Because of Possible Health Risk

IKM Recalls Product Because of Possible Health Risk

IKM Recalls Product Because of Possible Health Risk

ENvue Medical Appoints Industry Veteran Marc Waldman as Vice President, Commercial
Navitas Organics Voluntarily Recalls Select Lots of 8oz Organic Chia Seeds Because of Possible Health Risk

Navitas Organics Voluntarily Recalls Select Lots of 8oz Organic Chia Seeds Because of Possible Health Risk

Health Roads and Bonterra Forge Partnership to Convert Social-Care Documentation Into Medicaid-Reimbursable Claims
SciSparc Successfully Completes Acquisition of IP Portfolio, Advances Toward Immediate Commercialization
IKM Recalls Product Because of Possible Health Risk

IKM Recalls Product Because of Possible Health Risk

At FTC’s Request, Court Halts Operations of Deceptive Health Care Telemarketers

At FTC’s Request, Court Halts Operations of Deceptive Health Care Telemarketers

IKM Recalls Product Because of Possible Health Risk

IKM Recalls Product Because of Possible Health Risk

Parable Hospitality Launches, Setting a New Standard for Hotel Management With an Innovative Owner-First Model
CD Bioparticles Announces Advanced Engineering Platform for OMV-Based Bacterial Vaccine Development
Despite cost constraints, employers continue to invest in leave programs, WTW survey finds
Protecting Football Players’ Brains: Breakthrough Study Reinforces Vielight’s Red-Light Therapy Technology
Immunovant to Report Financial Results for the Third Quarter Ended December 31, 2025, and Provide Business Update on Friday, February 6, 2026

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions